FDA warns of ‘grave’ knock-on effects from Eagle decision

The US Food and Drug Administration (FDA) has warned a US Court of Appeals for the DC Circuit decision awarding market exclusivity to Eagle Pharmaceuticals for a cancer drug will have “grave” consequences for patient access.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Teva and Eagle try to block Bendeka generic

1 July 2021 Teva and Eagle Pharmaceuticals are suing to block a generic version of its leukemia drug Bendeka, arguing its patents still have plenty of time to run.

Americas

Fed Circuit affirms generic maker’s win over Eagle

11 May 2020 The US Court of Appeals for the Federal Circuit has affirmed a generic maker’s victory over pharmaceutical company Eagle Pharmaceuticals in a case involving cancer drug Belrapzo.

Big Pharma

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

18 December 2019 US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.

More on this story

Americas

Teva and Eagle try to block Bendeka generic

1 July 2021 Teva and Eagle Pharmaceuticals are suing to block a generic version of its leukemia drug Bendeka, arguing its patents still have plenty of time to run.

Americas

Fed Circuit affirms generic maker’s win over Eagle

11 May 2020 The US Court of Appeals for the Federal Circuit has affirmed a generic maker’s victory over pharmaceutical company Eagle Pharmaceuticals in a case involving cancer drug Belrapzo.

Big Pharma

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

18 December 2019 US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.

More on this story

Americas

Teva and Eagle try to block Bendeka generic

1 July 2021 Teva and Eagle Pharmaceuticals are suing to block a generic version of its leukemia drug Bendeka, arguing its patents still have plenty of time to run.

Americas

Fed Circuit affirms generic maker’s win over Eagle

11 May 2020 The US Court of Appeals for the Federal Circuit has affirmed a generic maker’s victory over pharmaceutical company Eagle Pharmaceuticals in a case involving cancer drug Belrapzo.

Big Pharma

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

18 December 2019 US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.